Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Harvard Business School
Chubb
Julphar
Fish and Richardson
Fuji
Boehringer Ingelheim
Medtronic
UBS
US Department of Justice

Generated: October 17, 2017

DrugPatentWatch Database Preview

Sodium iodide i-123 - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium iodide i-123 and what is the scope of sodium iodide i-123 freedom to operate?

Sodium iodide i-123
is the generic ingredient in one branded drug marketed by Mallinkrodt Nuclear, Ge Healthcare, and Cardinal Health 418, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred drug master file entries for sodium iodide i-123. Two suppliers are listed for this compound.

Summary for Generic Name: sodium iodide i-123

US Patents:0
Tradenames:1
Applicants:3
NDAs:4
Drug Master File Entries: see list1400
Suppliers / Packagers: see list2
Clinical Trials: see list2,510
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sodium iodide i-123 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
SODIUM IODIDE I 123
sodium iodide i-123
CAPSULE;ORAL017630-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 123
sodium iodide i-123
CAPSULE;ORAL071910-001Feb 28, 1989AARXNoNo► Subscribe► Subscribe► Subscribe
Cardinal Health 418
SODIUM IODIDE I 123
sodium iodide i-123
CAPSULE;ORAL018671-003May 27, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Cardinal Health 418
SODIUM IODIDE I 123
sodium iodide i-123
CAPSULE;ORAL018671-002May 27, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 123
sodium iodide i-123
CAPSULE;ORAL071909-001Feb 28, 1989AARXNoNo► Subscribe► Subscribe► Subscribe
Cardinal Health 418
SODIUM IODIDE I 123
sodium iodide i-123
CAPSULE;ORAL018671-001May 27, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Ge Healthcare
SODIUM IODIDE I 123
sodium iodide i-123
SOLUTION;ORAL017630-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Daiichi Sankyo
McKinsey
UBS
Boehringer Ingelheim
Merck
Cantor Fitzgerald
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot